Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observation of the Effect and Mechanism of Multi Tunnel Minimally Invasive Treatment for Xanthelasma Palpebrarum

NCT06869291 is registered in ClinicalTrials.gov with Fuzhou First General Hospital Skin Disease Prevention and Control Hospital as lead sponsor.

NCT NCT06869291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06869291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observation of the Effect and Mechanism of Multi Tunnel Minimally Invasive Treatment for Xanthelasma Palpebrarum
Lead sponsor
Fuzhou First General Hospital Skin Disease Prevention and Control Hospital
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
February 1, 2025
Completion date
February 1, 2029
Enrollment
270 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

xanthelasma palpebrarum